Erick Rowinsky News Today

Biogen (NASDAQ:BIIB – Get Free Report) had its price objective boosted by equities researchers at HSBC from $339.00 to $342.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. HSBC’s price target would indicate a potential upside of 57.23% […]

Summit Global Investments purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,088 shares of the biotechnology company’s stock, valued at approximately $1,575,000. Several other institutional investors have also recently made changes to […]

Summit Global Investments bought a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 6,088 shares of the biotechnology company’s stock, valued at approximately $1,575,000. Several other large investors also recently bought and sold shares of BIIB. International Assets […]

Oppenheimer reissued their outperform rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research report report published on Monday morning, Benzinga reports. The brokerage currently has a $270.00 target price on the biotechnology company’s stock. Several other research analysts have also recently weighed in on the stock. Truist Financial reiterated a buy rating […]

Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twenty-seven brokerages that are currently covering the firm, MarketBeat reports. Nine research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. The average 1 year price objective […]

Investment House LLC lessened its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in Biogen were worth $846,000 as of its most recent SEC filing. […]

Investment House LLC reduced its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in […]

Biogen (NASDAQ:BIIB – Free Report) had its target price upped by Wedbush from $213.00 to $215.00 in a report published on Thursday morning, Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q2 2024 earnings at $3.43 EPS, Q4 2024 earnings at $4.30 EPS, FY2024 […]

Biogen (NASDAQ:BIIB – Free Report) had its target price trimmed by Barclays from $215.00 to $200.00 in a report published on Thursday morning, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. BIIB has been the topic of several other research reports. Wedbush upped their target price on Biogen from […]

Gitterman Wealth Management LLC purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 980 shares of the biotechnology company’s stock, valued at approximately $254,000. Other institutional investors have also added to or reduced […]